Medical Research Future Fund
15
9
11
0
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 15 trials
20%
3 trials in Phase 3/4
0%
0 of 0 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (15)
CHAPTER: Clonal Haematopoiesis Assessment: Prevention, Treatment and Research
Role: collaborator
Modulation of Stem Cell Differentiation in Individuals With High Risk Clonal Haematopoiesis
Role: collaborator
Immunosuppression and COVID-19 Boosters
Role: collaborator
Technology Assisted Cognitive Behavioural Therapy Intervention for Anxiety in People Living With Cognitive Impairment
Role: collaborator
Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer
Role: collaborator
PRIORITY-CONNECT 2 Trial
Role: collaborator
Single Dose of Antenatal Corticosteroids for Pregnancies at Risk of Preterm Delivery (SNACS)
Role: collaborator
Integrated Healthy Lifestyle and Pain Care for People With Musculoskeletal Conditions Living in Rural Areas.
Role: collaborator
Enhancing Utility of Neuropsychological Evaluation for Earlier and Effective Diagnosis of Dementia in Parkinson's Disease
Role: collaborator
Generation Victoria Cohort 2020s: A Statewide Longitudinal Cohort Study of Victorian Children and Their Parents
Role: collaborator
ErythroPOietin Alfa to Prevent Mortality and Reduce Severe Disability in Critically Ill TRAUMA Patients
Role: collaborator
A Master Trial Assessing the Technical Feasibility of First-In-Human Real-Time Image Guided Radiation Therapy Methods
Role: collaborator
Dosimetry, Safety and Potential Benefit of 177Lu-PSMA-617 Prior to Prostatectomy
Role: collaborator
Precision Medicine for Every Child With Cancer
Role: collaborator
INCremental Dialysis to Improve Health Outcomes in People Starting Haemodialysis (INCH-HD)
Role: collaborator
All 15 trials loaded